198 related articles for article (PubMed ID: 6981636)
21. [Use of flow cytometry for HLA B27 phenotyping: study of a HLA B7/HLA B27 double marker technique].
Ulrich G
Allerg Immunol (Paris); 1997 Jan; 29(1):11-4. PubMed ID: 9213414
[TBL] [Abstract][Full Text] [Related]
22. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27.
Wakefield D; Easter J; Robinson P; Graham D; Penny R
Clin Exp Immunol; 1986 Jan; 63(1):49-57. PubMed ID: 3485486
[TBL] [Abstract][Full Text] [Related]
23. HLA-B27 phenotyping with flow cytometry: further improvement by multiple monoclonal antibodies.
Hoffmann JJ; Janssen WC
Clin Chem; 1997 Oct; 43(10):1975-81. PubMed ID: 9342021
[TBL] [Abstract][Full Text] [Related]
24. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
25. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
Aparicio P; Vega MA; López de Castro JA
J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
[TBL] [Abstract][Full Text] [Related]
26. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
Ebringer A
Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
[TBL] [Abstract][Full Text] [Related]
27. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease.
Schwimmbeck PL; Yu DT; Oldstone MB
J Exp Med; 1987 Jul; 166(1):173-81. PubMed ID: 2439632
[TBL] [Abstract][Full Text] [Related]
29. Identification of several functional subgroups of HLA-B27 by restriction of the activity of antiviral T killer lymphocytes.
Toubert A; Gomard E; Grumet FC; Amor B; Muller JY; Levy JP
Immunogenetics; 1984; 20(5):513-25. PubMed ID: 6094341
[TBL] [Abstract][Full Text] [Related]
30. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
Sullivan JS; Geczy AF
Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
[TBL] [Abstract][Full Text] [Related]
31. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
Yannelli JR; Moore LC; Engelhard VH
J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of Com-B27, a fluorescein-conjugated mouse anti-HLA-B27 reagent.
Coates E; Rees TJ; Darke C
Eur J Immunogenet; 2003 Aug; 30(4):271-4. PubMed ID: 12919288
[TBL] [Abstract][Full Text] [Related]
33. Strong association of HLA-B27 heavy chain with beta 2-microglobulin.
Tran TM; Horejsí V; Weinreich S; Pla M; Breur BS; Capková J; Flieger M; Ivanyi P; Ivasková E
Hum Immunol; 2000 Dec; 61(12):1197-201. PubMed ID: 11163075
[TBL] [Abstract][Full Text] [Related]
34. B7-CREG and ankylosing spondylitis.
Khan MA
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):129-33. PubMed ID: 6606463
[TBL] [Abstract][Full Text] [Related]
35. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
[TBL] [Abstract][Full Text] [Related]
36. One-tube HLA-B27/B2708 typing by flow cytometry using two "Anti-HLA-B27" monoclonal antibody reagents.
Darke C; Coates E
Cytometry B Clin Cytom; 2010 Jan; 78(1):21-30. PubMed ID: 19693889
[TBL] [Abstract][Full Text] [Related]
37. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
Taurog JD; el-Zaatari FA
J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
[TBL] [Abstract][Full Text] [Related]
38. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.
Parham P; Brodsky FM
Hum Immunol; 1981 Dec; 3(4):277-99. PubMed ID: 7035415
[TBL] [Abstract][Full Text] [Related]
39. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
Aparicio P; Jaraquemada D; López de Castro JA
J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
[TBL] [Abstract][Full Text] [Related]
40. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
